The role of zinc supplementation on the metallothionein system in children with autism spectrum disorder
The present research was carried out to elucidate the role of zinc (Zn) supplementation on the plasma concentration and gene expression, as well as the effects on cognitive-motor performance, in a cohort of children with autism spectrum disorder (ASD). The study was performed on a cohort of 30 pediatric subjects with ASD, encompassing an age range of 3–8 years. The impact of Zn supplementation was investigated in 3 months (or 12 weeks) on the ASD children. Each daily dosage of Zn was calculated as being equal to the body weight in kg plus 15–20 mg. The effect of Zn was also evaluated on the serum level of metallothionein 1 (MT-1A), and the severity of autism via scores on the Childhood Autism Rating Scale. The effect of Zn was investigated on the gene expression of MT1-A before and after Zn supplementation. The data of the present study showed an increase in cognitive-motor performance and an increased serum metallothionein concentration, as well as a significant lowering in the circulating serum levels of copper (Cu) following Zn supplementation. In the cohort of ASD patients, the genetic expression of MT-1 was higher after Zn therapy than before the treatment. In conclusion, Zn supplementation might be an important factor in the treatment of children with ASD.
KeywordsAutism Cognitive motor performance Zinc Metallothionine
Autism spectrum disorder
Childhood Autism Rating Scale
Central nervous system
Enzyme-linked immunosorbent assay
Polymerase chain reaction
Test of gross motor development
All authors confirmed they have contributed to the intellectual content of this paper and have met the following three requirements: (a) significant contributions to the conception and design, acquisition of data, or analysis and interpretation of data; (b) drafting or revising the article for intellectual content; and (c) final approval of the published article.
Compliance with ethical standards
Conflict of interest
The authors declare no potential conflicts of interest with respect to the authorship, and/or publication of this article.
All procedures performed were in accordance with the ethical standards of the institutional and/or national research committee, and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Written informed consent obtained from the guardians of all participants.
- 1.Bjørklund G (2013) The role of zinc and copper in autism spectrum disorders. Acta Neurobiol Exp (Wars) 73:225–236Google Scholar
- 5.Kogan MD, Vladutiu CJ, Schieve LA, Ghandour RM, Blumberg SJ, Zablotsky B, Perrin JM, Shattuck P, Kuhlthau KA, Harwood RL, Lu MC (2018) The prevalence of parent-reported autism spectrum disorder among US children. Pediatrics 142:e20174161. https://doi.org/10.1542/peds.2017-4161 CrossRefPubMedGoogle Scholar
- 9.Joyce PI, Fratta P, Landman AS, Mcgoldrick P, Wackerhage H, Groves M, Busam BS, Galino J, Corrochano S, Beskina OA, Esapa C, Ryder E, Carter S, Stewart M, Codner G, Hilton H, Teboul L, Tucker J, Lionikas A, Estabel J, Ramirez-Solis R, White JK, Brandner S, Plagnol V, Bennet DL, Abramov AY, Greensmith L, Fisher EM, Acevedo-Arozena A (2016) Deficiency of the zinc finger protein ZFP106 causes motor and sensory neurodegeneration. Hum Mol Genet 25:291–307CrossRefGoogle Scholar
- 15.Petro A, Sexton HG, Miranda C, Rastogi A, Freedman JH, Levin ED (2016) Persisting neurobehavioral effects of developmental copper exposure in wildtype and metallothionein 1 and 2 knockout mice. BMC Pharmacol Toxicol 17:55. https://doi.org/10.1186/s40360-016-0096-3 CrossRefPubMedPubMedCentralGoogle Scholar
- 20.American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders: DSM-IV-TR. American Psychiatric Association, WashingtonGoogle Scholar
- 21.Rutter M, Le CA, Lord C (2003) Autism diagnostic interview-revised (ADI-R). Western Psychological Services, Los AngelesGoogle Scholar
- 22.Schopler E, Reichler RJ, Rochen-Renner B (1998) The Childhood Autism Rating Scale (CARS). Western Psychological Services, Los AngelsGoogle Scholar
- 23.Ulrich BD (2000) Test of gross motor development, 2nd edn. Pro-Ed, AustinGoogle Scholar
- 24.Ulvi H, Yigiter R, Yoldas T, Dolu Y, Var A, Mungen B (2002) Manganese, zinc and copper contents in hair and their serum concentration. in patients with epilepsy. Eastern J Med 7:3–5Google Scholar
- 27.Macedoni-Lukšič M, Gosar D, Bjørklund G, Oražem J, Kodrič J, Lešnik- Musek P, Zupančič M, France-Štiglic A, Sešek-Briški A, Neubauer D, Osredkar J (2015) Levels of metals in the blood and specific porphyrins in the urine in children with autism spectrum disorders. Biol Trace Elem Res 163:2–10CrossRefGoogle Scholar
- 33.Colombo J, Zavaleta N, Kannass KN, Lazarte F, Albornoz C, Kapa LL, Caulfield LE (2014) Zinc supplementation sustained normative neurodevelopment in a randomized, controlled trial of Peruvian infants aged 6–18 months. J Nutr 144:1298–1305. https://doi.org/10.3945/jn.113.189365 CrossRefPubMedPubMedCentralGoogle Scholar
- 35.Russo AJ, Bazin AP, Bigega R, Carlson RS 3rd, Cole MG, Contreras DC, Galvin MB, Gaydorus SS, Holik SD, Jenkins GP, Jones BM, Languell PA, Lyman PJ, March KP, Meuer KA, Peterson SR, Piedmonte MT, Quinn MG, Smaranda NC, Steves PL, Taylor HP, Waddingham TE, Warren JS (2012) Plasma copper and zinc concentration in individuals with autism correlate with selected symptom severity. Nutr Metab Insights 5:41–47. https://doi.org/10.4137/NMI.S8761 CrossRefPubMedPubMedCentralGoogle Scholar
- 39.Breslin CM, Rudisill ME (2011) The effect of visual supports on performance of the TGMD-2 for children with autism spectrum disorder. Adapt Phys Activ Q 28:343–353Google Scholar
- 42.Locks LM, Manji KP, McDonald CM, Kupka R, Kisenge R, Aboud S, Wang M, Bellinger DC, Fawzi WW, Duggan CP (2017) The effect of daily zinc and/or multivitamin supplements on early childhood development in Tanzania: results from a randomized controlled trial. Matern Child Nutr. https://doi.org/10.1111/mcn.12306 CrossRefPubMedGoogle Scholar